Sexual function variable in diabetic women
Key points
- Research suggests that women with type 1 or insulin-dependent diabetes have decreased sexual function and increased sexual distress during the second half of the menstrual cycle after ovulation and before menstruation (also known as the luteal phase of the menstrual cycle).
- Compared with the controls, women with diabetes had decreased sexual function and increased sexual distress during the luteal, but not the follicular phase of the menstrual cycle.
- During the luteal phase, patients had higher total testosterone levels and lower estrogen and progesterone levels compared with the controls.
- "Decreased sexual function occurs independently of mood deflections and does not seem to be influenced by glycemic (sugar) control," Salonia and colleagues write.
Research suggests that women with type 1 or insulin-dependent diabetes have decreased sexual function and increased sexual distress during the second half of the menstrual cycle after ovulation and before menstruation (also known as the luteal phase of the menstrual cycle).
A group of Italian researchers lead by Dr. Andrea Salonia, of University Vita-Salute San Raffaele, Milano, evaluated the sexual function and endocrine profile in 50 fertile women with type 1 diabetes, noting the follicular (roughly the first two weeks of the menstrual cycle) and luteal phases of the menstrual cycle, and compared the findings with those of 47 controls.
Compared with the controls, women with diabetes had decreased sexual function and increased sexual distress during the luteal, but not the follicular phase of the menstrual cycle.
During the luteal phase, patients had higher total testosterone levels and lower estrogen and progesterone levels compared with the controls.
"Decreased sexual function occurs independently of mood deflections and does not seem to be influenced by glycemic (sugar) control," Salonia and colleagues write.
The variability of sexual function with different phases of the menstrual cycle may have implications on the clinical assessment in diabetics, they conclude.
SOURCE: Diabetes Care 2005;29:312-316.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsIslet cell transplantation restores type 1 diabetics' blood sugar defense mechanisms
Type 1 diabetes (T1D) patients who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving…
20 December 2014
NewsBehavioral interventions to prevent progression to diabetes equally effective in men and women
Behavioural and drug interventions aiming to prevent people with prediabetes progressing to full blown type 2 diabetes are equally effective for both sexes at preventing progression and reducing weight, according to a…
29 November 2014
NewsLow birth weight linked to higher incidence of type 2 diabetes in African American women
African American women born at a low or very low birth weight may be at a higher risk for developing type 2 diabetes. The findings, which appear in Diabetes Care, may explain in part the higher occurrence of type 2…
